US capacity deal with Biogen Idec part of Eisai's global production re-jig
This article was originally published in Scrip
Executive Summary
Eisai is continuing to shake out its worldwide manufacturing operations with a decision to lease out and possibly divest to Biogen Idec part of its production facilities in Research Triangle Park (RTP) in the US.